Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.780
-0.080 (-4.30%)
Feb 20, 2026, 2:38 PM EST - Market open
Genprex Market Cap
Genprex has a market cap or net worth of $4.13 million as of February 20, 2026. Its market cap has decreased by -6.70% in one year.
Market Cap
4.13M
Enterprise Value
3.21M
1-Year Change
-6.70%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $4.13M, a decrease of -93.26%. That is a compound annual growth rate of -28.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 4.31M | 6.29% |
| Dec 31, 2025 | 4.06M | -43.99% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 4.94M |
| Acurx Pharmaceuticals | 4.71M |
| PMGC Holdings | 4.71M |
| Dermata Therapeutics | 4.61M |
| 60 Degrees Pharmaceuticals | 4.17M |
| Indaptus Therapeutics | 4.13M |
| GeoVax Labs | 4.10M |
| Cardio Diagnostics Holdings | 4.09M |